EVOK News and Press, Evoke Pharma Inc. From 05/05/22

Most people think of penny stocks as shares of companies trading for pennies. The standard definition considers these as stocks under $5, but you can’t argue with popular opinion. The exciting part about penny stocks under $1 is the volatility and gain potential they hold. Ca...

SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its first quarter 2022 financial results on Tu...

Check These 3 Penny Stocks to Watch as EVOK Explodes With shares of EVOK stock exploding today, there is a lot of momentum with penny stocks right now. As is usually the case during intraday trading, many penny stocks climb, and some fall. But, knowing how to find the right penny st...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, California-based Evoke Pharma (NASDAQ: EVOK ) is up a jaw-dropping 130% so far on surprising regulatory news. This morning, Evoke announced that the U.S. Food and Drug Administration (FDA) has granted the compa...

Evoke Pharma, Inc. (NASDAQ: EVOK) has announced that the FDA has granted new drug product exclusivity for the company’s GIMOTI nasal spray.  Evoke has been given exclusive marketing rights for three years from the original date of approval under the Hatch-Waxman Ac...

Gainers: Evoke Pharma (EVOK) +151%. Avadel Pharmaceuticals (AVDL) +26%. Arch Resources (ARCH) +21%. Magnachip Semiconductor (MX) +20%. TradeUP Global (TUGCU) +20%. Jiuzi Holdings (JZXN) +19%. Forge Global Holdings (FRGE) +18%. Morphic Holding (MORF) +16%. Flexsteel Industries (FLXS) +15%. Sky...

SOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced that it has been granted new drug product exclusivity by the U.S. Food and Drug ...

SOLANA BEACH, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, announced today that GIMOTI ® (metoclopramide) nasal spray a novel treatment solution f...

Shares of Evoke Pharma Inc. (NASDAQ:EVOK) traded at a new 52-week high today of $11.10. So far today approximately 79.3 million shares have been exchanged, as compared to an average 30-day volume of 83,000 shares. Evoke Pharma Inc is a specialty pharmaceutical company focused on the deve...

SOLANA BEACH, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced that together with the research team at H.C. Wainwright & Co., it will host ...